Comparison of High Dose Ondansetron versus Low Dose Ondansetron for Prevention from Postansthesia Shivering

  • Behzad Nazemroaya ORCID Mail Department of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Parvin Sajedi ORCID Department of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Darioush Moradi Farsani ORCID Department of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
  • Naja Chaib ORCID Department of Anesthesiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Keywords:
Ondansetron, Shivering, postanesthesia shivering, General anesthesia

Abstract

Background: Postanesthesia shivering (PAS) is a very common anesthesia-related complication the not only is a discomfortable phenomenon for that patients, but can cause undesirable events and affect the patient’s prognosis negatively. This study compares the high dose ondansetron versus low dose of this agent for PAS control.
Methods: In this clinical trial 101 patients under general anesthesia for elective surgeries in three groups of premedication with high dose ondansetron (8mg) (n=33), low dose ondansetron (4mg) (n=34) and placebo (normal saline) (n=34) were evaluated. The agents were injected immediately before anesthesia induction, and hemodynamic data, nausea and vomiting incidence and shivering severity were compared.
Results: Mean arterial pressure and pulse rate significantly decreased within the time (P-value<0.05), while oxygen saturation, peripheral and central body temperature did not have statistically significant alterations (P-value>0.05). The duration of recovery room stays and use of meperidine for shivering control were not different in the three groups (P-value>0.05), while incidence of nausea and vomiting and shivering intensity in placebo treated group was worse than ondansetron treated groups regardless of the dose (P-value<0.05). Comparison of two ondansetron treated groups represented insignificant difference considering nausea and vomiting and shivering intensity (P-value>0.05).
Conclusion: Ondansetron use regardless of the dose was superior to placebo in terms of PAS intensity and nausea and vomiting prevention. Low dose of ondansetron (4mg) was superior to high dose (8 mg) considering the hemodynamic stability, while the two doses were similar in terms of PAS intensity, nausea and vomiting occurrence, duration of recovery room stay and meperidine requirement for shivering control.

References

[1] He K, Zhao H, Zhou H. Efficiency and safety of ondansetron in preventing postanaesthesia shivering. Efficiency and safety of ondansetron in preventing postanaesthesia shivering. 2016; 98(6):358-66.
[2] Noaman M, Mohamed FI, Diab AA-HA. Ondansetron versus Pethidine for The Prevention of Postoperative Shivering. Journal of Medical Arts. 2019;1(1):53-7.
[3] Suresh JS, Arora A, George A, Vinayak SR. Comparison of intravenous butorphanol, ondansetron and tramadol for control of shivering during regional anesthesia: A prospective, randomized double-blind study. Anaesthesia, Pain & Intensive Care. 2013;17(1):33-9.
[4] Alfonsi P. Postanaesthetic shivering. Epidemiology, pathophysiology and approaches to prevention and management. Minerva Anestesiol. 2003; 69(5):438-42.
[5] Mathews S, Al Mulla A, Varghese P, Radim K, Mumtaz S. Postanaesthetic shivering‐a new look at tramadol. Anaesthesia. 2002; 57(4):387-403.
[6] Dal D, Kose A, Honca M, Akinci S, Basgul E, Aypar U. Efficacy of prophylactic ketamine in preventing postoperative shivering. Br J Anaesth. 2005; 95(2):189-92.
[7] Mohta M, Kumari N, Tyagi A, Sethi A, Agarwal D, Singh M. Tramadol for prevention of postanaesthetic shivering: a randomised double‐blind comparison with pethidine. Anaesthesia. 2009; 64(2):141-6.
[8] Park SM, Mangat HS, Berger K, Rosengart AJ. Efficacy spectrum of antishivering medications: meta-analysis of randomized controlled trials. Crit Care Med. 2012; 40(11):3070-82.
[9] Sharma S, Raghu K, Nikhil N, Rajaram G, Kumar S, Singh S, editors. Prophylactic administration of ondansetron for prevention of shivering during spinal anesthesia. The Indian Anaesthetists Forum; 2018: Medknow Publications.
[10] Asl M, Isazadefar K, Mohammadian A, Khoshbaten M. Ondansetron and meperidine prevent postoperative shivering after general anesthesia. Middle East J Anaesthesiology. 2011; 21(1):67-70.
[11] Powell RM, Buggy DJ. Ondansetron given before induction of anesthesia reduces shivering after general anesthesia. Anesth Analg. 2000; 90(6):1423-7.
[12] Komatsu R, Orhan-Sungur M, In J, Podranski T, Bouillon T, Lauber R, et al. Ondansetron does not reduce the shivering threshold in healthy volunteers. Br J Anaesth. 2006; 96(6):732-7.
[13] Sajedi P, Nazemroaya B. Comparing the effectiveness of antishivering action of meperidine alfentanil, sufentanil, fentanyl and tramadol after general anesthesia. Shiraz E-Medical Journal .2006; 7(3):1-6.
[14] Lin H, Wang J, Jin Z, Hu Y, Huang W. Preventative effect of ondansetron on postanesthesia shivering in children undergoing caudal anesthesia: a randomized double-blinded clinical trial. Pediatr Res. 2016;79(1-1):96-9.
[15] Tie H-T, Su G-Z, He K, Liang S-R, Yuan H-W, Mou J-H. Efficacy and safety of ondansetron in preventing postanesthesia shivering: a meta-analysis of randomized controlled trials. BMC anesthesiol. 2014; 14(1):12.
[16] Crossley A, Mahajan R. The intensity of postoperative shivering is unrelated to axillary temperature. Anaesthesia.1994; 49(3):205-7.
[17] De Witte J, Daniel IS. Perioperative Shivering: Physiology and Pharmacology. Anesthesiology. 2002; 96(2-P):467-84.
[18] Browning RM, Fellingham WH, O’Loughlin EJ, Brown NA, Paech MJ. Prophylactic ondansetron does not prevent shivering or decrease shivering severity during cesarean delivery under combined spinal epidural anesthesia: a randomized trial. Reg Anesth Pain Med. 2013; 38(1):39-43.
[19] Lenhardt R. The effect of anesthesia on body temperature control. Front Biosci (Schol Ed). 2010;2(June 1):1145-54.
[20] Mahoori A, Noroozinia H, Hasani E, Soltanahmadi M. Comparison of ondansetron and meperidine for treatment of postoperative shivering: a randomized controlled clinical trial. Iran Red Crescent Med J. 2014; 16(8): e13079.
[21] Kelsaka E, Baris S, Karakaya D, Sarıhasan B. Comparison of ondansetron and meperidine for prevention of shivering in patients undergoing spinal anesthesia. Reg Anesth Pain Med. 2006; 31(1):40-5.
[22] Shakya B, Chaturvedi A, Sah B. Prophylactic low dose ketamine and ondansetron for prevention of shivering during spinal anaesthesia. J Anaesthesiol Clin Pharmacol. 2010; 26(4):465-9.
[23] Chowdhury AN LS, Ray AK, Baruah Alireza, Pirkhaefi. Comparison of Intravenous Ondansetron and Tramadol for Control of Shivering during Spinal Anaesthesia: A Prospective, Observer Blind Study. International J Contemporary Medical Research. 2018; 5(12):L7-L11.
[24] Chagaleti I AJ. Ondansetron versus Tramadol in Prevention of Postanesthesia shivering following caesarean section under spinal anesthesia. Global Journal for Research Analysis. 2015;4(2):4-7.
[25] Marashi SM, Soltani-Omid S, Mohammadi SS, Aghajani Y, Movafegh A. Comparing two different doses of intravenous ondansetron with placebo on attenuation of spinal-induced hypotension and shivering. Anesth Pain Med. 2014; 4(2).
Published
2020-08-18
How to Cite
1.
Nazemroaya B, Sajedi P, Moradi Farsani D, Chaib N. Comparison of High Dose Ondansetron versus Low Dose Ondansetron for Prevention from Postansthesia Shivering. Arch Anesth & Crit Care. 6(3):118-24.
Section
Research Article(s)